APO RESEARCH · REPORT
Clinical Trial Imaging
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
Product & engineering
Understand the product.
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
Selected research
Industry Research
Clinical Trial Imaging Industry Research Report 2026
Market perspective
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
According to the Segmentation of types, all the market of Clinical Trial Imaging can be divided into In-house Imaging Service and Central Imaging Service. The Central Imaging Service, it holds a comparatively larger share in global market, which accounts for about 69% in 2019.
Based on the Clinical Trial Imaging application, the Clinical Trial Imaging market is sub-segmented into several major Application, like Pharmaceutical Companies, Biotechnology Companies, Academic Institutes, Others, etc. Pharmaceutical Companies and Biotechnology Companies are the most important applications, which holds nearly 1/3 and 1/4 of the market in 2019.
Read the full market overview
From the view of region, North America and Europe have a larger market share in 2019 which account for about 1/3 and 27%, and will witness a stable growth in following years. Asia-Pacific and India hold a big market share also, and they will witness the comparatively bigger market share in the future.
The world TOP 5 players in the Clinical Trial Imaging market are ICON, ERT, McLaren, Bioclinica, Parexel. These Top 5 companies currently account for more than 43% of the total market share and are expected to retain their dominating hold over the market during the forecast period.
Report Scope
This report quantifies the global Clinical Trial Imaging market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Clinical Trial Imaging.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Clinical Trial Imaging Market by Company
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Clinical Trial Imaging Segment by Type
In-house Imaging Service
Central Imaging Service
Clinical Trial Imaging Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others
Clinical Trial Imaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Trial Imaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trial Imaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Clinical Trial Imaging companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- In-house Imaging Service
- Central Imaging Service
Applications
- Pharmaceutical Companies
- Biotechnology Companies
- Academic Institutes
- Others
Companies covered
- ICON
- ERT
- McLaren
- Bioclinica
- Parexel
- BioTelemetry
- ProScan Imaging
- Imaging Endpoints
- Radiant Sage
- Micron, Inc.
- Intrinsic Imaging
- Median Technologies
- Cardiovascular Imaging Technologies
- Banook Medical
- IXICO
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Clinical Trial Imaging by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 In-house Imaging Service
- 2.2.3 Central Imaging Service
- 2.3 Clinical Trial Imaging by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Companies
- 2.3.3 Biotechnology Companies
- 2.3.4 Academic Institutes
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Clinical Trial Imaging Breakdown Data by Type
- 3.1 Global Clinical Trial Imaging Historic Market Size by Type (2021-2026)
- 3.2 Global Clinical Trial Imaging Forecasted Market Size by Type (2027-2032)
4 Clinical Trial Imaging Breakdown Data by Application
- 4.1 Global Clinical Trial Imaging Historic Market Size by Application (2021-2026)
- 4.2 Global Clinical Trial Imaging Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Clinical Trial Imaging Market Perspective (2021-2032)
- 5.2 Global Clinical Trial Imaging Growth Trends by Region
- 5.2.1 Global Clinical Trial Imaging Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Clinical Trial Imaging Historic Market Size by Region (2021-2026)
- 5.2.3 Clinical Trial Imaging Forecasted Market Size by Region (2027-2032)
- 5.3 Clinical Trial Imaging Market Dynamics
- 5.3.1 Clinical Trial Imaging Industry Trends
- 5.3.2 Clinical Trial Imaging Market Drivers
- 5.3.3 Clinical Trial Imaging Market Challenges
- 5.3.4 Clinical Trial Imaging Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Clinical Trial Imaging Players by Revenue
- 6.1.1 Global Top Clinical Trial Imaging Players by Revenue (2021-2026)
- 6.1.2 Global Clinical Trial Imaging Revenue Market Share by Players (2021-2026)
- 6.2 Global Clinical Trial Imaging Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Clinical Trial Imaging Head Office and Area Served
- 6.4 Global Clinical Trial Imaging Players, Product Type & Application
- 6.5 Global Clinical Trial Imaging Manufacturers Established Date
- 6.6 Global Clinical Trial Imaging Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Clinical Trial Imaging Market Size (2021-2032)
- 7.2 North America Clinical Trial Imaging Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Clinical Trial Imaging Market Size by Country (2021-2026)
- 7.4 North America Clinical Trial Imaging Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Clinical Trial Imaging Market Size (2021-2032)
- 8.2 Europe Clinical Trial Imaging Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Clinical Trial Imaging Market Size by Country (2021-2026)
- 8.4 Europe Clinical Trial Imaging Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Clinical Trial Imaging Market Size (2021-2032)
- 9.2 Asia-Pacific Clinical Trial Imaging Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Clinical Trial Imaging Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Clinical Trial Imaging Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Clinical Trial Imaging Market Size (2021-2032)
- 10.2 South America Clinical Trial Imaging Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Clinical Trial Imaging Market Size by Country (2021-2026)
- 10.4 South America Clinical Trial Imaging Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Clinical Trial Imaging Market Size (2021-2032)
- 11.2 Middle East & Africa Clinical Trial Imaging Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Clinical Trial Imaging Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Clinical Trial Imaging Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 ICON
- 12.1.1 ICON Company Information
- 12.1.2 ICON Business Overview
- 12.1.3 ICON Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.1.4 ICON Clinical Trial Imaging Product Portfolio
- 12.1.5 ICON Recent Developments
- 12.2 ERT
- 12.2.1 ERT Company Information
- 12.2.2 ERT Business Overview
- 12.2.3 ERT Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.2.4 ERT Clinical Trial Imaging Product Portfolio
- 12.2.5 ERT Recent Developments
- 12.3 McLaren
- 12.3.1 McLaren Company Information
- 12.3.2 McLaren Business Overview
- 12.3.3 McLaren Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.3.4 McLaren Clinical Trial Imaging Product Portfolio
- 12.3.5 McLaren Recent Developments
- 12.4 Bioclinica
- 12.4.1 Bioclinica Company Information
- 12.4.2 Bioclinica Business Overview
- 12.4.3 Bioclinica Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.4.4 Bioclinica Clinical Trial Imaging Product Portfolio
- 12.4.5 Bioclinica Recent Developments
- 12.5 Parexel
- 12.5.1 Parexel Company Information
- 12.5.2 Parexel Business Overview
- 12.5.3 Parexel Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.5.4 Parexel Clinical Trial Imaging Product Portfolio
- 12.5.5 Parexel Recent Developments
- 12.6 BioTelemetry
- 12.6.1 BioTelemetry Company Information
- 12.6.2 BioTelemetry Business Overview
- 12.6.3 BioTelemetry Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.6.4 BioTelemetry Clinical Trial Imaging Product Portfolio
- 12.6.5 BioTelemetry Recent Developments
- 12.7 ProScan Imaging
- 12.7.1 ProScan Imaging Company Information
- 12.7.2 ProScan Imaging Business Overview
- 12.7.3 ProScan Imaging Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.7.4 ProScan Imaging Clinical Trial Imaging Product Portfolio
- 12.7.5 ProScan Imaging Recent Developments
- 12.8 Imaging Endpoints
- 12.8.1 Imaging Endpoints Company Information
- 12.8.2 Imaging Endpoints Business Overview
- 12.8.3 Imaging Endpoints Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.8.4 Imaging Endpoints Clinical Trial Imaging Product Portfolio
- 12.8.5 Imaging Endpoints Recent Developments
- 12.9 Radiant Sage
- 12.9.1 Radiant Sage Company Information
- 12.9.2 Radiant Sage Business Overview
- 12.9.3 Radiant Sage Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.9.4 Radiant Sage Clinical Trial Imaging Product Portfolio
- 12.9.5 Radiant Sage Recent Developments
- 12.10 Micron, Inc.
- 12.10.1 Micron, Inc. Company Information
- 12.10.2 Micron, Inc. Business Overview
- 12.10.3 Micron, Inc. Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.10.4 Micron, Inc. Clinical Trial Imaging Product Portfolio
- 12.10.5 Micron, Inc. Recent Developments
- 12.11 Intrinsic Imaging
- 12.11.1 Intrinsic Imaging Company Information
- 12.11.2 Intrinsic Imaging Business Overview
- 12.11.3 Intrinsic Imaging Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.11.4 Intrinsic Imaging Clinical Trial Imaging Product Portfolio
- 12.11.5 Intrinsic Imaging Recent Developments
- 12.12 Median Technologies
- 12.12.1 Median Technologies Company Information
- 12.12.2 Median Technologies Business Overview
- 12.12.3 Median Technologies Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.12.4 Median Technologies Clinical Trial Imaging Product Portfolio
- 12.12.5 Median Technologies Recent Developments
- 12.13 Cardiovascular Imaging Technologies
- 12.13.1 Cardiovascular Imaging Technologies Company Information
- 12.13.2 Cardiovascular Imaging Technologies Business Overview
- 12.13.3 Cardiovascular Imaging Technologies Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Product Portfolio
- 12.13.5 Cardiovascular Imaging Technologies Recent Developments
- 12.14 Banook Medical
- 12.14.1 Banook Medical Company Information
- 12.14.2 Banook Medical Business Overview
- 12.14.3 Banook Medical Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.14.4 Banook Medical Clinical Trial Imaging Product Portfolio
- 12.14.5 Banook Medical Recent Developments
- 12.15 IXICO
- 12.15.1 IXICO Company Information
- 12.15.2 IXICO Business Overview
- 12.15.3 IXICO Revenue in Clinical Trial Imaging Business (2021-2026)
- 12.15.4 IXICO Clinical Trial Imaging Product Portfolio
- 12.15.5 IXICO Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst